The products and their related methods appearing in the list below may be covered by one or more of the following U.S. or international patents. Other U.S. patents, international equivalent patents, and/or distinct international patents may also apply or be pending. The reader is hereby placed on notice of Reprise Biomedical’s rights in the U.S. and/or international patents associated with the following products and their related methods.
To the extent a product, product name, method, feature, or design does not appear on the following list, such omission does not constitute a waiver of any or all intellectual property rights that Reprise Biomedical has established in any of its products, product names, methods, features, or designs. Other Reprise Biomedical products and methods not listed here may be protected by one or more patents.
This website is provided to satisfy the virtual patent marking provisions of various jurisdictions, including the virtual patent marking provisions of the America Invents Act.
- Three issued U.S. Patents (U.S. 8,470,520, U.S. 9,290,738, U.S. 15,079,985) with corresponding issued patents in major international markets covering perfusion decellularization.
- Multiple additional patents pending in the U.S. and major international markets, all licenced to Reprise Biomedical within the field of use for acellular products.
SM-00158 Rev. A 05/20